TherapeuticsMD reported $-1.77M in EBIT for its fiscal quarter ending in September of 2023.





Ebit Change Date
AbbVie USD 4.73B 1.08B Mar/2026
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD 56.04M 63.94M Dec/2025
CSL USD 2.64B 116M Dec/2025
Grifols EUR 320.55M 91.01M Dec/2025
Novo Nordisk DKK 5.18B 37.04B Jun/2025
Pfizer USD 4.65B 71M Dec/2025
TherapeuticsMD USD -1.77M 699K Sep/2023